Stephens Investment Management Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-37,037
| Closed | -$6.8M | – | 196 |
|
|
2021
Q2 | $6.8M | Buy |
37,037
+1,805
| +5% | +$332K | 0.09% | 156 |
|
|
2021
Q1 | $5.39M | Buy |
35,232
+1,730
| +5% | +$265K | 0.08% | 161 |
|
|
2020
Q4 | $5.23M | Sell |
33,502
-567
| -2% | -$88.6K | 0.08% | 158 |
|
|
2020
Q3 | $3.9M | Sell |
34,069
-744
| -2% | -$85.1K | 0.07% | 156 |
|
|
2020
Q2 | $3.91M | Buy |
34,813
+4,737
| +16% | +$532K | 0.07% | 151 |
|
|
2020
Q1 | $2.7M | Sell |
30,076
-1,590
| -5% | -$143K | 0.07% | 145 |
|
|
2019
Q4 | $3.43M | Buy |
31,666
+23
| +0.1% | +$2.49K | 0.06% | 151 |
|
|
2019
Q3 | $3.1M | Buy |
31,643
+8,007
| +34% | +$784K | 0.06% | 150 |
|
|
2019
Q2 | $3.1M | Buy |
23,636
+2,477
| +12% | +$324K | 0.06% | 163 |
|
|
2019
Q1 | $2.86M | Buy |
21,159
+652
| +3% | +$88.1K | 0.06% | 163 |
|
|
2018
Q4 | $2M | Sell |
20,507
-957
| -4% | -$93.2K | 0.05% | 163 |
|
|
2018
Q3 | $2.98M | Buy |
21,464
+750
| +4% | +$104K | 0.06% | 161 |
|
|
2018
Q2 | $2.52M | Buy |
20,714
+246
| +1% | +$29.9K | 0.05% | 160 |
|
|
2018
Q1 | $2.28M | Buy |
20,468
+2,756
| +16% | +$307K | 0.05% | 166 |
|
|
2017
Q4 | $2.12M | Buy |
17,712
+1,461
| +9% | +$175K | 0.05% | 173 |
|
|
2017
Q3 | $2.28M | Hold |
16,251
| – | – | 0.05% | 166 |
|
|
2017
Q2 | $1.98M | Buy |
16,251
+4,044
| +33% | +$492K | 0.05% | 167 |
|
|
2017
Q1 | $1.48M | Buy |
12,207
+406
| +3% | +$49.2K | 0.04% | 169 |
|
|
2016
Q4 | $1.44M | Buy |
11,801
+5
| +0% | +$612 | 0.04% | 165 |
|
|
2016
Q3 | $1.45M | Buy |
11,796
+6,706
| +132% | +$821K | 0.04% | 162 |
|
|
2016
Q2 | $594K | Sell |
5,090
-640
| -11% | -$74.7K | 0.02% | 172 |
|
|
2016
Q1 | $798K | Sell |
5,730
-330
| -5% | -$46K | 0.03% | 165 |
|
|
2015
Q4 | $1.16M | Sell |
6,060
-335
| -5% | -$63.9K | 0.04% | 162 |
|
|
2015
Q3 | $1M | Sell |
6,395
-395
| -6% | -$61.8K | 0.04% | 168 |
|
|
2015
Q2 | $1.23M | Buy |
6,790
+185
| +3% | +$33.4K | 0.04% | 170 |
|
|
2015
Q1 | $1.15M | Buy |
6,605
+470
| +8% | +$81.5K | 0.03% | 167 |
|
|
2014
Q4 | $1.14M | Buy |
6,135
+65
| +1% | +$12K | 0.03% | 168 |
|
|
2014
Q3 | $1.01M | Buy |
6,070
+160
| +3% | +$26.5K | 0.03% | 180 |
|
|
2014
Q2 | $923K | Sell |
5,910
-250
| -4% | -$39K | 0.03% | 189 |
|
|
2014
Q1 | $937K | Sell |
6,160
-1,155
| -16% | -$176K | 0.03% | 190 |
|
|
2013
Q4 | $973K | Buy |
7,315
+1,380
| +23% | +$184K | 0.03% | 181 |
|
|
2013
Q3 | $689K | Buy |
5,935
+50
| +0.8% | +$5.81K | 0.02% | 189 |
|
|
2013
Q2 | $543K | Buy |
+5,885
| New | +$543K | 0.03% | 185 |
|